Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants

ClinicalTrials.gov ID: NCT03631732

Public ClinicalTrials.gov record NCT03631732. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 7:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Multicenter, Open-Label Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the efficacy of switching from a regimen of 2 nucleos(t)Ide reverse transcriptase inhibitors (NRTIs) and a third agent to a fixed dose combination (FDC) of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) versus continuing their baseline regimen in HIV-1 infected, virologically suppressed African American participants.

Study identification

NCT ID
NCT03631732
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
496 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 27, 2018
Primary completion
Aug 11, 2019
Completion
Aug 18, 2020
Last update posted
Sep 4, 2021

2018 – 2020

United States locations

U.S. sites
82
U.S. states
24
U.S. cities
56
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Alabama Medical Group, PC Mobile Alabama 36608
Kaiser Permanente Los Angeles Medical Center Los Angeles California 90027
Ruane Clinical Research Group Inc. Los Angeles California 90036
Mills Clinical Research Los Angeles California 90069
Highland Hospital- Alameda Health System Oakland California 94602
Kaiser Permanente Oakland California 94611
One Community Health Sacramento California 95811
Kaiser Permanente Sacramento California 95825
Kaiser Permanente, Department of Infectious Diseases San Leandro California 94577
Whitman-Walker Health Washington D.C. District of Columbia 20005
Georgetown University Hospital Washington D.C. District of Columbia 20007
Dupont Circle Physician's Group Washington D.C. District of Columbia 20009
Washington Health Institute Washington D.C. District of Columbia 20017
Capital Medical Associates, PC Washington D.C. District of Columbia 20036
The GW Medical Faculty Associates Washington D.C. District of Columbia 20037
Midland Florida Clinical Research Center, LLC DeLand Florida 32720
Therafirst Medical Center Fort Lauderdale Florida 33308
Gary J. Richmond, M.D., P.A. Fort Lauderdale Florida 33316
Midway Immunology and Research Center Ft. Pierce Florida 34982
AHF- The Kinder Medical Group Miami Florida 33133
University of Miami School of Medicine Division of Infectious Disease Miami Florida 33136
AIDS Healthcare Foundation - South Beach Miami Beach Florida 33140
Orlando Immunology Center Orlando Florida 32803-1851
St. Joseph's Hospital Comprehensive Research Institute Tampa Florida 33614
AIDS Research & Treatment Center of the Treasure Coast Vero Beach Florida 32960
Triple O Research Institute, P.A. West Palm Beach Florida 33407
Emory Hospital Midtown Infectious Disease Clinic Atlanta Georgia 30308
Atlanta ID Group, PC Atlanta Georgia 30309
Augusta University Medical Center Augusta Georgia 30912
Infectious Disease Specialist of Atlanta Decatur Georgia 30033
Mercer University, Department of Internal Medicine Macon Georgia 31201
Chatham County Health Department Savannah Georgia 31401
Howard Brown Health Center Chicago Illinois 60613
NorthStar Medical Center Chicago Illinois 60657
Indiana CTSI Clinical Research Center Indianapolis Indiana 46077
University Medical Center- New Orleans (UMCNO) New Orleans Louisiana 70112
SLVHCS Building J, 7th floor, Outpatient Infectious Disease Clinic New Orleans Louisiana 70119
CrescentCare Health New Orleans Louisiana 70130
Brigham and Women's Hospital Boston Massachusetts 02115
Boston University Medical Center Boston Massachusetts 02118
Claudia T. Martorell, MD, LLC d/b/a The Research Institute Springfield Massachusetts 01105
Be Well Medical Center Berkley Michigan 48072
Wayne State University- Integrative Bioscience Center Detroit Michigan 48201
Henry Ford Hospital Detroit Michigan 48202
St. John Newland Medical Associates Southfield Michigan 48075
Hennepin County Medical Center, Positive Care Clinic Minneapolis Minnesota 55414
G.V. 'Sonny' Montgomery VAMC Jackson Mississippi 39216
Southampton Clinical Research St Louis Missouri 63108
Clinical: Saint Louis University, New Hope Clinic St Louis Missouri 63110
Washington University School of Medicine St Louis Missouri 63110
Southampton Healthcare, Inc. St Louis Missouri 63139
Huntridge Family Clinic Las Vegas Nevada 89104
Prime Healthcare Services- St. Michael's LLC d/b/a Saint Michael's Medical Center Newark New Jersey 07102
North Shore University Hospital/Division of Infectious Diseases Manhasset New York 11030
Jacobi Medical Center The Bronx New York 10461
Montefiore Medical Center The Bronx New York 10467
NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514
UT Physicians Charlotte North Carolina 28207
Duke University Health System Durham North Carolina 27710
East Carolina University, The Brody School of Medicine, ECU Adult Specialty Care Greenville North Carolina 27834
Rosedale Infectious Diseases Huntersville North Carolina 28078
AHF Pensacola North Carolina 32504
Wake Forest University Health Sciences Winston-Salem North Carolina 27157
University of Cincinnati College of Medicine Cincinnati Ohio 45267
MetroHealth Medical Center Cleveland Ohio 44109
Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19066
Philadelphia FIGHT Community Health Centers Philadelphia Pennsylvania 19107
Palmetto Health Richland Columbia South Carolina 29203
St. Jude Children's Research Hospital Memphis Tennessee 38105
Central Texas Clinical Research Austin Texas 78705
St. Hope Foundation Bellaire Texas 77401
AIDS Arms, Inc. DBA Prism Health North Texas Dallas Texas 75208
North Texas Infectious Diseases Consultants, P.A. Dallas Texas 75246
Tarrant County Infectious Disease Associates Fort Worth Texas 76104
Therapeutic Concepts, PA Houston Texas 77004
Thomas Street Health Center Houston Texas 77030
Research Access Network Houston Texas 77098
The Crofoot Research Center, INC (dba Gordon E. Crofoot MD PA) Houston Texas 77098
DCOL Center for Clinical Research Longview Texas 75605
Community Health Care, Hilltop Medical Clinic Tacoma Washington 98405
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03631732, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2021 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03631732 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →